4 completed. 4 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 4 |
| Phase 2 | 1 | Completed 1 |
Follow tetomilast: new trials by email Literature Review of tetomilast trials Research Report on tetomilast
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Dose-finding and Confirmatory Trial of OPC-6535 in Patients With Active Crohn's Disease Placebo, OPC-6535 - Crohn's Disease | Phase 2 / Phase 3 | Completed | Otsuka Pharmaceutical Co., Ltd. | 191 | 2009-10-01 | 2021-04-06 |
| CORE: A Study of OPC-6535 With Asacol® in Maintaining Ulcerative Colitis (UC) Remission OPC-6535, Asacol® - Ulcerative Colitis | Phase 3 | Completed | Otsuka Pharmaceutical Development & Commercialization, Inc. | 1725 | 2004-05-01 | 2007-06-21 |
| FACTS I: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative Colitis OPC-6535 Tablets (drug) - Ulcerative Colitis | Phase 3 | Completed | Otsuka Pharmaceutical Development & Commercialization, Inc. | 375 | 2003-05-01 | 2012-05-10 |
| FACTS II: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative Colitis OPC-6535 Tablets (drug) - Ulcerative Colitis | Phase 3 | Completed | Otsuka Pharmaceutical Development & Commercialization, Inc. | 375 | 2003-05-01 | 2012-05-10 |
Colitis, Ulcerative (3) · Colitis (1) · Crohn Disease (1) · Hemorrhage (1) · Recurrence (1) · Ulcer (1)
Otsuka Pharmaceutical Development & Commercialization, Inc. (3) · Otsuka Pharmaceutical Co., Ltd. (1)
United States (3) · Japan (1) · South Korea (1)
Katsuhisa Saito (1)